JOAN CANTON: Open Payments
NPI 1538505300 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,235 in 91 payments from 12 companies in 2025. Trend: 2023 $998 · 2024 $1,445 · 2025 $2,235
Food & beverage: $2,016Education: $218
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 29 | $599 |
| Otsuka America Pharmaceutical, Inc. | 11 | $375 |
| Vanda Pharmaceuticals Inc. | 8 | $244 |
| Neurocrine BioSciences, Inc. | 5 | $217 |
| E.R. Squibb & Sons, L.L.C. | 9 | $212 |
| Janssen Pharmaceuticals, Inc | 7 | $190 |
| Alkermes, Inc. | 12 | $181 |
| Bausch Health US, LLC | 4 | $91 |
| Noven Therapeutics, LLC | 2 | $48 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
Products named: AUSTEDO XR, ABILIFY ASIMTUFII, FANAPT, INGREZZA, COBENFY, ARISTADA, SPRAVATO, APLENZIN.
Industry payments across CA — which companies pay providers there.
